Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer

Introduction ECRG4/C2ORF40 is a potential tumor suppressor gene (TSG) recently identified in esophageal carcinoma. Its expression, gene copy number and prognostic value have never been explored in breast cancer. Methods Using DNA microarray and array-based comparative genomic hybridization (aCGH), we examined ECRG4 mRNA expression and copy number alterations in 353 invasive breast cancer samples and normal breast (NB) samples. A meta-analysis was done on a large public retrospective gene expression dataset (n = 1,387) in search of correlations between ECRG4 expression and histo-clinical features including survival. Results ECRG4 was underexpressed in 94.3% of cancers when compared to NB. aCGH data revealed ECRG4 loss in 18% of tumors, suggesting that DNA loss is not the main mechanism of underexpression. Meta-analysis showed that ECRG4 expression was significantly higher in tumors displaying earlier stage, smaller size, negative axillary lymph node status, lower grade, and normal-like subtype. Higher expression was also associated with disease-free survival (DFS; HR = 0.84 [0.76–0.92], p = 0.0002) and overall survival (OS; HR = 0.72 [0.63–0.83], p = 5.0E-06). In multivariate analysis including the other histo-clinical prognostic features, ECRG4 expression remained the only prognostic factor for DFS and OS. Conclusions Our data suggest that ECRG4 is a candidate TSG in breast cancer, the expression of which may help improve the prognostication. If functional analyses confirm this TSG role, restoring ECRG4 expression in the tumor may represent a promising therapeutic approach.

• Publication year

  2011

• Venue

  PLoS ONE

• Publication date

  2011-11-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0027656PMID 22110708PMCID 3218004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• COSMIC: the catalogue of somatic mutations in cancer

  2011cited by this paper
• Ecrg4 expression and its product augurin in the choroid plexus: impact on fetal brain development, cerebrospinal fluid homeostasis and neuroprogenitor cell response to CNS injury

  2011cited by this paper
• Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis

  2011cited by this paper
• A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma

  2011cited by this paper
• Processing of proaugurin is required to suppress proliferation of tumor cell lines.

  2011cited by this paper
• Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells

  2010cited by this paper
• Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients

  2010cited by this paper
• Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion

  2010influential reference
• ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma

  2009influential reference
• Hypermethylation of Genes for Diagnosis and Risk Stratification of Prostate Cancer

  2009cited by this paper
• Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.

  2009cited by this paper
• Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo

  2009influential reference
• Predicting protein-protein interactions in Arabidopsis thaliana through integration of orthology, gene ontology and co-expression

  2009cited by this paper
• Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.

  2007cited by this paper
• Identification of novel peptide hormones in the human proteome by hidden Markov model screening.

  2007cited by this paper
• Integrated profiling of basal and luminal breast cancers.

  2007influential reference
• Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

  2007cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2006cited by this paper
• Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

  2006cited by this paper
• Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.

  2006cited by this paper
• An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

  2005cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2005cited by this paper
• Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

  2005cited by this paper
• Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma.

  2003cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003influential reference
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• [Cloning and identification of cDNA fragments related to human esophageal cancer].

  1998cited by this paper

• MYB: A potential therapeutic target in triple-negative breast cancer based on the PI3K/AKT signaling pathway.

  2026cites this paper
• Inhibition of IRE1α kinase increases ferroptosis resistance in triple-negative breast cancer cells.

  2026cites this paper
• LEP and FOXO1 genes, as a proposed tumor suppressor autophagic cell death related genes, can be targeted by antidiabetic therapy in nondiabetic breast cancer patients

  2025influential citation
• Targeting PABPC1: A Therapeutic Strategy of Natural Ganoderma Meroterpenoid LZ22 against Triple-Negative Breast Cancer Proliferation.

  2025cites this paper
• Pan-Cancer Analyses of Shared and Distinct Gene Expression in 17 Cancers: Rethinking Cancer Classification and Moving Beyond “One Drug, One Disease” Paradigm of Pharmaceutical Innovation

  2025cites this paper
• Comprehensive analysis of metabolism-related gene biomarkers reveals their impact on the diagnosis and prognosis of triple-negative breast cancer

  2025influential citation
• Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosis

  2025cites this paper
• Investigating the Prognostic Role of Telomerase-Related Cellular Senescence Gene Signatures in Breast Cancer Using Machine Learning

  2025cites this paper
• Drug repurposing through pathway perturbation dynamics: A systems biology approach for precision oncology

  2025cites this paper
• Integrated edge information and pathway topology for drug-disease associations

  2024cites this paper
• Aberrant expression of collagen type X in solid tumor stroma is associated with EMT, immunosuppressive and pro-metastatic pathways, bone marrow stromal cell signatures, and poor survival prognosis

  2024cites this paper
• Restoring social deficits in IRSp53-deleted mice: chemogenetic inhibition of ventral dentate gyrus Emx1-expressing cells

  2024cites this paper
• MAZ-mediated up-regulation of BCKDK reprograms glucose metabolism and promotes growth by regulating glucose-6-phosphate dehydrogenase stability in triple-negative breast cancer

  2024cites this paper
• CD8+ T cell‑related KCTD5 contributes to malignant progression and unfavorable clinical outcome of patients with triple‑negative breast cancer

  2024cites this paper
• Txnrd1 as a prognosticator for recurrence, metastasis and response to neoadjuvant chemotherapy and radiotherapy in breast cancer patients

  2024cites this paper
• Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype

  2023cites this paper
• Schlafen 12 Slows TNBC Tumor Growth, Induces Luminal Markers, and Predicts Favorable Survival

  2023cites this paper
• Annotated Compendium of 102 Breast Cancer Gene-Expression Datasets

  2023cites this paper
• Expression of Esophageal Cancer-Related Gene 4: A Candidate Tumor Suppressor Gene, Regulated by Methylation Level in Laryngeal Malignant Tumor

  2023cites this paper
• A drug repurposing method based on inhibition effect on gene regulatory network

  2023cites this paper
• Identification of stromal cell proportion-related genes in the breast cancer tumor microenvironment using CorDelSFS feature selection: implications for tumor progression and prognosis

  2023cites this paper
• Complex and pleiotropic signaling pathways regulated by the secreted protein augurin

  2023cites this paper
• A potential link between aberrant expression of ECRG4 and atrial fibrillation

  2023cites this paper
• C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway

  2022cites this paper
• Loss of Ecrg4 improves calcium oxalate nephropathy

  2022cites this paper
• Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer

  2022influential citation
• Identi cation of Subtype-Speci c Prognostic Biomarkers in Breast Cancer

  2022cites this paper
• CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression

  2022cites this paper
• TAaCGH Suite for Detecting Cancer—Specific Copy Number Changes Using Topological Signatures

  2022cites this paper
• Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy

  2022cites this paper
• Downregulated Copper Homeostasis-Related Gene FOXO1 as a Novel Indicator for the Prognosis and Immune Response of Breast Cancer

  2022cites this paper
• LncRNA ZNF582-AS1 Expression and Methylation in Breast Cancer and Its Biological and Clinical Implications

  2022cites this paper
• Type I IFN stimulates IFI16-mediated aromatase expression in adipocytes that promotes E2-dependent growth of ER-positive breast cancer

  2022influential citation
• Immunogenomic landscape analyses of immune molecule signature-based risk panel for patients with triple-negative breast cancer

  2022cites this paper
• Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer

  2022cites this paper
• Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis

  2022cites this paper
• Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors

  2022cites this paper
• HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer

  2022cites this paper
• Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer

  2022cites this paper
• Transcriptomics based prediction of metastasis in TNBC patients: Challenges in cross-platforms validation

  2021cites this paper
• The serine/threonine kinase MINK1 directly regulates the function of promigratory proteins

  2021cites this paper
• Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer

  2021cites this paper
• Genome Instability-Derived Genes Are Novel Prognostic Biomarkers for Triple-Negative Breast Cancer

  2021cites this paper
• Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival

  2021influential citation
• Aberrant expression of the esophageal carcinoma related gene 4 as a prognostic signature for hepatocellular carcinoma.

  2021cites this paper
• A novel three-long noncoding RNA risk score system for the prognostic prediction of triple-negative breast cancer.

  2021cites this paper
• CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1

  2021influential citation
• Dysregulation of ECRG4 is associated with malignant properties and of prognostic importance in human gastric cancer

  2021cites this paper
• The Expression and Prognostic Value of SUMO1-Activating Enzyme Subunit 1 and Its Potential Mechanism in Triple-Negative Breast Cancer

  2021cites this paper
• Eight immune-related genes predict survival outcomes and immune characteristics in breast cancer

  2020cites this paper
• Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor–Positive Breast Cancer

  2020cites this paper
• Pregnancy reprograms the epigenome of mammary epithelial cells and blocks the development of premalignant lesions

  2020cites this paper
• Title: Revisiting the Stress concept in the context of solid tumors prognostic: a role for the Stress Granules? Running title: Stress granules as novel actors in cancer er progression

  2020cites this paper
• Development of a nine-lncRNA signature as a novel prognostic marker of estrogen receptor-negative breast cancer.

  2020cites this paper
• The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype

  2020cites this paper
• ECRG4 regulates neutrophil recruitment and CD44 expression during the inflammatory response to injury

  2020cites this paper
• A Stemness and EMT Based Gene Expression Signature Identifies Phenotypic Plasticity and is A Predictive but Not Prognostic Biomarker for Breast Cancer

  2020cites this paper
• BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.

  2020cites this paper
• Construction of a Novel 3-lncRNA Risk Score System for the Prognostic Prediction of Triple-Negative Breast Cancer

  2020cites this paper
• Identifying Biomarkers to Predict the Progression and Prognosis of Breast Cancer by Weighted Gene Co-expression Network Analysis

  2020cites this paper
• TILRR (FREM1 isoform 2) is a prognostic biomarker correlated with immune infiltration in breast cancer

  2020cites this paper
• Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?

  2020cites this paper
• Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients

  2020cites this paper
• ECRG4 Represses Cell Proliferation and Invasiveness via NFIC/OGN/NF-κB Signaling Pathway in Bladder Cancer

  2020cites this paper
• Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer

  2020cites this paper
• A Ca2+-ATPase Regulates E-cadherin Biogenesis and Epithelial–Mesenchymal Transition in Breast Cancer Cells

  2019cites this paper
• COHCAP: an integrative genomic pipeline for single-nucleotide resolution DNA methylation analysis

  2019cites this paper
• The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells.

  2019cites this paper
• Ecrg4 deficiency extends the replicative capacity of neural stem cells in a Foxg1-dependent manner

  2019cites this paper
• Grade-specific diagnostic and prognostic biomarkers in breast cancer.

  2019cites this paper
• ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer

  2019cites this paper
• Parsimonious Gene Correlation Network Analysis (PGCNA): a tool to define modular gene co-expression for refined molecular stratification in cancer

  2019cites this paper
• Esophageal cancer related gene-4 inhibits the migration and proliferation of oral squamous cell carcinoma through BC200 lncRNA/MMP-9 and -13 signaling pathway.

  2019cites this paper
• Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer

  2019influential citation
• Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian versus Western Populations.

  2019cites this paper
• Potential functions of esophageal cancer-related gene-4 in the cardiovascular system

  2019cites this paper
• OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts

  2019cites this paper
• Comparison of the marginal hazard model and the sub-distribution hazard model for competing risks under an assumed copula

  2019cites this paper
• Comprehensive analysis of dysregulated lncRNAs and their competing endogenous RNA network in triple-negative breast cancer.

  2019cites this paper
• CrossICC: iterative consensus clustering of cross-platform gene expression data without adjusting batch effect

  2019cites this paper
• Expression of Fibroblast Growth Factor 5 (FGF5) and Its Influence on Survival of Breast Cancer Patients

  2018influential citation
• MELK expression correlates with tumor mitotic activity but is not required for cancer growth

  2018cites this paper
• Gene Selection and Survival Prediction Under Dependent Censoring

  2018cites this paper
• ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer

  2018cites this paper
• The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

  2018cites this paper
• Personalized dynamic prediction of death according to tumour progression and high-dimensional genetic factors: Meta-analysis with a joint model

  2018cites this paper
• The expression of ubiquitin‐specific peptidase 8 and its prognostic role in patients with breast cancer

  2018cites this paper
• Defining common principles of gene co-expression refines molecular stratification in cancer

  2018cites this paper
• Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress

  2018cites this paper
• Asymptotic null distribution of the modified likelihood ratio test for homogeneity in finite mixture models

  2018cites this paper
• Estimation of age effect with change‐points on survival of cancer patients

  2018cites this paper
• ECRG4: a new potential target in precision medicine

  2018cites this paper
• Integrated network analysis and machine learning approach for the identification of key genes of triple‐negative breast cancer

  2018cites this paper
• Downregulation and DNA methylation of ECRG4 in gastric cancer

  2018cites this paper
• A Moonlighting Role for SPCA2 in E-cadherin Biogenesis and Suppression of Epithelial-Mesenchymal Transition

  2018cites this paper
• Annexin A7 is correlated with better clinical outcomes of patients with breast cancer

  2018cites this paper
• UBE2C is involved in the functions of ECRG4 on esophageal squamous cell carcinoma.

  2018cites this paper
• Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells

  2017cites this paper
• Hedgehog-mesenchyme gene signature identifies bi-modal prognosis in luminal and basal breast cancer sub-types.

  2017cites this paper
• Gene expression information improves reliability of receptor status in breast cancer patients

  2017cites this paper